Compare Cassava Sciences Inc (FLNA) vs Opendoor Technologies Inc (OPEN) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Opendoor Technologies (OPEN) trades at $4.65, up 2.2% today, with a neutral technical signal and bearish moving averages. The company reported a net loss of $1.30 billion on $4.37 billion revenue in 2025, with a negative net margin of -35.25%. Recent news highlights a 7-11% stock jump amid iBuyer rallies and the upcoming Q2 2026 earnings report on August 4, 2026, while the company shutters its India operations to focus on AI-driven efficiency.

The outlook remains challenged by persistent losses and high debt, but cost discipline and margin improvements under the new CEO offer a potential path to EBITDA break-even. Key risks include housing market volatility and interest rate sensitivity, while analyst consensus is cautious with 65% hold ratings. The stock's low P/S ratio of 1 suggests undervaluation relative to peers if execution improves.